Skip to content

EyePoint, Inc. EYPT Interest Expense

Discontinued — last reported Q4 '25

Interest Expense at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$12.9M+48.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$2.78M-6.9%
HRO
HarrowHROW
$5.5M-16.1%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$582K-9.5%
LQD
Liquidia CorporationLQDA
$6.49M+39.1%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$2.85M-6.4%

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+98.4%
Enterprise value$1.15B+111%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: EyePoint, Inc. ’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's interest expense?
EyePoint, Inc. (EYPT) reported interest expense of $8.25K in Q4 2025.
What is the long-term trend for EyePoint, Inc. 's interest expense?
Over 3 years (2021 to 2025), EyePoint, Inc. 's interest expense has grown at a -81.8% compound annual growth rate (CAGR), from $5.5M to $33K.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.